Skip to main content

Table 1 Characteristics of study patients

From: Lifetime risk assessment in cholesterol management among hypertensive patients: observational cross-sectional study based on electronic health record data

 Women N = 4344Men N = 2773P-value
Demographics
 Mean age (years), mean (SD)70 (12)66 (12)< 0.001
Medication (ATC), n (%)
 Lipid-lowering medication (C10)2310 (53)1400 (50)0.027
 Other cardiac therapy e.g. antiarrhythmics, nitrates (C01)936 (22)429 (15)< 0.001
 ACE-inhibitors, Angiotensin II antagonists (C09)3531 (81)2330 (84)0.003
 Diuretics (C03)1370 (32)538 (19)< 0.001
 Beta blockers (C07)2477 (57)1312 (47)< 0.001
 Calcium Channel Blockers (C08)2150 (49)1379 (50)0.85
 Other antihypertensives (C02)114 (3)73 (3)0.97
Co-morbidity (ICD-10), n (%)
  Heart failure (I50)95 (2)31 (1)< 0.001
 Atrial fibrillation and flutter (I48)295 (7)207 (7)0.28
Plasma LDL-C level, mean (SD)
 All2.88 (0.88)2.85 (0.88)< 0.001a
 With LLM2.75 (0.97)2.68 (0.98)< 0.001a
 Without LLM3.03 (0.73)3.01 (0.73)0.25a
  1. Abbreviations. LLM lipid lowering medication, LDL-C low-density lipoprotein
  2. aAdjusted for age